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bstract
Conjugated linoleic acid (CLA) supplementation has been reported to induce insulin resistance in animals and humans, however, the underlying
echanisms remain unclear. The aim of this study was to examine the direct effects of CLA on leptin and adiponectin secretion, two hormones
ith actions known to influence insulin sensitivity. Isolated rat adipocytes were incubated with CLA (1–200M) in the absence and presence of
nsulin (1.6 nM). CLA inhibited both basal and insulin-stimulated leptin gene expression and secretion (−30 to −40%, P < 0.05–0.01). CLA also
nhibited basal adiponectin production (−20 to −40%, P < 0.05–0.01), but not in the presence of insulin. CLA (50–200M) decreased basal glucose
ptake (P < 0.05–0.01) and significantly increased the proportion of glucose metabolized to lactate (P < 0.01). Insulin treatment partially prevented
he inhibitory effects of CLA on glucose uptake and induced a significant increase (P < 0.05–0.01) in the percentage of glucose metabolized to
actate. A strong inverse relationship was observed between the increase in the anaerobic utilization of glucose and the decreases of both leptin
nd adiponectin secretion. In addition, lipolysis and the expression of the adipogenic transcription factor PPAR were decreased by CLA. These
esults indicate that CLA inhibits leptin and adiponectin secretion and suggest that increased anaerobic metabolism of glucose may be involved in
hese effects. The inhibition of PPAR could also mediate the inhibition of adiponectin induced by CLA. Furthermore, the inhibition of leptin and
diponectin production induced by CLA may contribute to insulin resistance observed in CLA-treated animals and humans.
2007 Elsevier Ireland Ltd. All rights reserved.
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. Introduction
Conjugated linoleic acid (CLA) is a generic term for the posi-
ional and geometric isomers of linoleic acid [18:2(n− 6)]. This
atty acid is produced in the rumen of ruminant animals by the
ermentative bacteria, Butyrivibrio ﬁbrisolvens, which isomer-
zes linoleic acid into CLA (Kepler et al., 1966). Another source
f CLA in ruminants is synthesis via  9-desaturase of trans-
1 octadecanoic acid (Griinari et al., 2000). The major dietary
ources of CLA are dairy products as well as ruminant meats
uch as beef and lamb (Chin et al., 1992). CLA isomers can also
e chemically and commercially produced by heating linoleic
cid in the presence of alkali or by partial hydrogenation of
inoleic acid (Banni, 2002).
∗ Corresponding author. Tel.: +34 948 425600; fax: +34 948 425649.
E-mail address: mjmoreno@unav.es (M.J. Moreno-Aliaga).
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oi:10.1016/j.mce.2007.01.013d rat adipocytes; Peroxisome proliferator-activated receptor 
CLA has been studied extensively due to its potential
eneficial effects in several disease states including cancer
Belury, 2002), atherosclerosis (McLeod et al., 2004), dia-
etes (Houseknecht et al., 1998), and obesity (Wang and Jones,
004a). CLA has also been reported to increase immune func-
ion (O’Shea et al., 2004). The majority of the studies conducted
n animals have demonstrated that CLA reduces body fat mass
Wang and Jones, 2004a,b), although in some studies no effects
f CLA on body composition were observed (Mirand et al.,
004). In contrast, the consensus from seventeen published stud-
es in human subjects is that CLA supplementation does not
ffect body weight or body composition (Tricon et al., 2005).
CLA supplementation has also been reported to be associated
ith deleterious effects including the development of insulinesistance and hyperinsulinaemia both in mice and humans
Tsuboyama-Kasaoka et al., 2000; Riserus et al., 2002, 2004).
Several studies have shown that CLA supplementation
ecreases circulating leptin concentrations (Medina et al., 2000;
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amasaki et al., 2003). It has been suggested that CLA-induced
eductions in circulating leptin levels are associated with the
eductions in fat mass caused by CLA (Wang and Jones,
004a,b), however, in the study by Medina et al. (2000), fat mass
as not reduced by CLA. Therefore, CLA might also directly
ffect leptin production. For example, incubation of 3T3-L1
dipocytes with trans-10, cis-12-CLA (t10c12 isomer: the CLA
somer suggested to be most effective at reducing fat mass in
nimals) inhibited leptin secretion and expression (Kang and
ariza, 2001). However, another more recent study found that
he t10c12 isomer increased leptin gene expression in cultures of
tromal vascular cells (SV cells) containing newly differentiated
uman adipocytes (Brown et al., 2004).
Adiponectin is a hormone specifically secreted by adipose
issue with important metabolic effects (Havel, 2004). Plasma
diponectin concentrations are decreased in obesity and are pos-
tively associated with whole-body insulin sensitivity (Stefan et
l., 2002a). Low adiponectin levels have been shown to pre-
ede and predict the onset of insulin resistance, type 2 diabetes
nd cardiovascular diseases (Hotta et al., 2001; Stefan et al.,
002b; Kumada et al., 2003). Two recent in vivo studies in mice
eported that the hyperinsulinaemia induced by CLA treatment
as preceded by decreases in leptin and adiponectin plasma lev-
ls (Ohashi et al., 2004; Poirier et al., 2005). These data suggest a
otential direct inhibitory action of CLA on adiponectin produc-
ion, however, the direct effect of CLA on adiponectin secretion
y adipocytes has not been investigated.
The aim of the present study was to investigate the in vitro
ffects of CLA on adiponectin and leptin production from pri-
ary rat adipocytes. Isolated adipocytes were attached to a
ollagen matrix and cultured with CLA for 96 h. This system
imulates normal basement membrane attachment and main-
ains adipocyte differentiation (Mueller et al., 1998), resulting in
more physiological environment compared to “free-floating”
dipocytes.
The effects of CLA on basal and insulin-stimulated glucose
tilization, lactate production and lipolysis were also studied. A
umber of studies have demonstrated that leptin production is
odulated by insulin responses to meals and dietary macronutri-
nt composition (Havel et al., 1999b; Havel, 2004; Perez-Matute
t al., 2005). The effect of insulin to stimulate leptin gene
xpression and secretion (Mueller et al., 1998) and the tran-
criptional activity of the leptin promoter (Moreno-Aliaga et al.,
001) is mediated by insulin’s actions to increase adipocyte glu-
ose utilization. Furthermore, insulin shifts glucose metabolism
rom anaerobic metabolism to lactate to mitochondrial oxidation
nd this metabolic change appears to contribute to the effects
f insulin to stimulate leptin production (Havel et al., 1999a;
ueller et al., 2000). Several studies have also suggested a role
f insulin in the regulation of adiponectin secretion although
ata were conflicting (Halleux et al., 2001; Fasshauer et al.,
002).
Adiponectin has been shown to be a target gene of the tran-
criptional factor PPAR (Iwaki et al., 2003), and several studies
ave demonstrated that the thiazolidinediones, selective lig-
nds of PPAR used in treatment of type 2 diabetes, increase
diponectin mRNA levels (Combs et al., 2002). Therefore, we
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lso examined the effects of CLA on PPAR gene expression in
ultured rat adipocytes.
. Materials and methods
.1. Materials
Media (Dulbecco’s modified Eagle’s medium, DMEM), minimal essen-
ial medium amino acids, penicillin/streptomycin, fetal bovine serum (FBS),
nd nystatin were purchased from Gibco-Invitrogen Life Technologies (Carls-
ad, CA, USA, Grand Island, NY, USA). Bovine serum albumin fraction V,
-(2-hydroxyethyl)-1-piperazineethansulfonic acid (HEPES), insulin and CLA
40% of 10t12c and 40% of 9c11t) were purchased from Sigma Chemical Co.
St. Louis, MO, USA). Collagen (Vitrogen 100) was obtained from Cohesion
echnologies (Palo Alto, CA, USA). 14C-glucose was obtained from Perkin-
lmer Life Science (Boston, MA, USA). Type I collagenase was purchased
rom Worthington Biochemical Corporation (Lakewood, NJ).
.2. Animals
Male Wistar rats (250–280 g) obtained from Applied Pharmacobiology Cen-
er (CIFA-Spain) were used to provide adipocytes isolated from the epididymal
at depot. The animals were housed in cages in temperature-controlled rooms
22 ± 2 ◦C) with a 12-h light:12-h dark cycle. All experimental procedures were
erformed according to National and Institutional Guidelines for Animal Care
nd Use and approved by the Ethical Committee for Animal Care and Use at the
niversity of Navarra, Spain. Animals were euthanized, and epididymal adipose
issue was removed.
.3. Adipocyte isolation and culture
Adipocytes were isolated from epididymal fat depots. Epididymal fat was
inced and digested in HEPES buffer (pH 7.4; containing 5 mM d-glucose, 2%
SA, 135 mM NaCl, 2.2 mM CaCl2·2H2O, 1.25 mM MgSO4·7H2O, 0.45 mM
H2PO4, 2.17 mM Na2HPO4, and 10 mM HEPES) with type I collagenase
1.25 mg/ml per 0.5 g tissue) at 37 ◦C with gentle shaking for 30 min. The
esulting cell suspension was diluted in HEPES-phosphate buffer and the iso-
ated adipocytes were then separated from the undigested tissue by filtration
hrough a 400M nylon mesh and washed three times. Isolated adipocytes
ere then resuspended in DMEM supplemented with 1% FBS and incubated
or 40 min at 37 ◦C. The isolated adipocytes (150l of 2:1 ratio of packed cells
o medium) were then plated on 500l of a collagen matrix (Vitrogen 100,
ohesion Technologies, Palo Alto, CA) in 6-well culture plates. After 50 min
f incubation at 37 ◦C, the culture media containing 0 or 1.6 nM insulin and the
ifferent concentrations (0, 1, 10, 50, 100 and 200M) of the assayed CLA were
dded and the cells were maintained in an incubator at 37 ◦C in 5% CO2 for up
o 96 h.
.4. Assays
Leptin concentrations in the medium were determined after 96 h of culture
sing a radioimmunoassay for rat leptin (Linco Research, St. Charles, MO).
diponectin concentrations were analysed using a highly sensitive mouse/rat
diponectin ELISA kit (B-Bridge International Inc, USA). Glucose and lactate
oncentrations in the media were measured by an Autoanalyzer (Cobas Roche
iagnostic, Basel, Switzerland) (Moreno-Aliaga et al., 2002).
.5. Analysis of mRNA
Leptin and PPAR mRNA levels were determined by Northern blotting.
he leptin cDNA probe was a 388-bp fragment of mouse leptin cDNA, which
as kindly provided by Dr. Charles Mobbs (Mount Sinai School of Medicine,
ew York). The PPAR2 cDNA probe (GenBank accession no. Y12882) was
593-bp fragment of rat cDNA, and the primers used were 5′-TCTGATTAT-
GGTGAAACTC-3′ (sense 43–62) and 5′-TTTCTACTCTTTTTGTGGATC-
′ (antisense 592–612). The 18S ribosomal probe was obtained from Ambion
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Ambion, Austin, TX). RNA was extracted according to the Gibco Life Tech-
ologies procedure using Trizol (Life Technologies Inc., Grand Island, NY). The
V absorbance and integrity gels were used to estimate RNA. Leptin, PPAR2
nd 18S cDNA probes were labeled by random priming (Rediprime kit, Amer-
ham, Buckinghamshire, UK) in the presence of 32P dCTP (3000 Ci/mmol,
mersham). Unincorporated nucleotides were removed using NucTrap probe
urification columns (Stratagene, La Jolla, CA). For each tissue sample, 7g of
otal RNA were fractionated by electrophoresis on a denaturing 1% agarose gel
ontaining 2.2 M formaldehyde and 1× MOPS running buffer. One microliter
f a 50g/ml ethidium bromide (Gibco BRL, Gaithersburg, MD) stock solution
as added in order to check RNA integrity and even loading. After electrophore-
is, RNA was transferred to nylon membrane (Duralon-UV, Stratagene, La Jolla,
A) by overnight capillary transfer and UV cross-linked (Stratalinker 1800,
tratagene, La Jolla, CA). Blots were then hybridized for 1 h at 68 ◦C in pres-
nce of labeled cDNA probe (2 × 106 cpm/ml Express Hyb solution, Clontech,
alo Alto, CA and 1 × 106 cpm/ml with the 18S cDNA probe). After washing at
igh stringency, blots were exposed to X-ray films with an intensifying screen at
80 ◦C. The expression level of 18S ribosomal RNA was determined and used
s an internal control to correct minor variation in total RNA amount.
.6. Lipolysis
Lipolysis was assessed by measuring glycerol release into the media at 96 h.
lycerol was determined using an Autoanalyzer following the manufacturer
nstructions (Cobas Roche Diagnostic, Basel, Switzerland).
.7. Statistical analysis
The amount of carbon released as lactate per amount of carbon taken up as
lucose over 96 h was calculated as [lactate]/[glucose], where  is the differ-
nce, and expressed as a percentage. The amount of glucose incorporated to CO2
as calculated as (dpm collected on Whatman 1 strip) (total glucose)/total dpm
nd expressed as a percentage of total glucose utilized. The amount of glucose
ncorporated into lipid was calculated as [(dpm extracted in 1 ml chloroform)
total glucose)/total dpm] × 10 ml chloroform. This value was normalized over
he amount of total lipid recovered from the well and expressed as a percentage
f total glucose utilized.
The experimental results from each adipocyte suspension prepared from a
ingle animal were analyzed in relation to a control well from the same sus-
ension. For this reason, the statistical analysis of the data was performed by a
epeated measures ANOVA followed by a Dunnet’s post-test (GraphPad Prism,
3
c
ig. 1. Effects of CLA (1–200M) on basal (A) and insulin-stimulated (B) leptin m
ibosomal RNA was determined and used as an internal control to correct minor variat
xperiments. Effects of different concentrations of CLA on basal (C) and insulin-stim
ean ± S.E.) *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control (cells without CLA anlar Endocrinology 268 (2007) 50–58
raphPad Software Inc, San Diego, CA, USA). Results were also analyzed
nd expressed as the percentage of the control. All data were presented as
ean ± S.E. Differences were considered as statistically significant at P < 0.05.
ifferent animals were used to provide adipocytes for the measurements of
lucose incorporation into lipid and glucose oxidation than those used for mea-
urement of leptin and adiponectin secretion, glucose utilization and lactate
roduction.
. Results
.1. Effects of CLA on leptin expression and secretion
Incubation of adipocytes with CLA at concentrations from
to 200M inhibited both basal (by 35–65%) and insulin-
timulated leptin gene expression (by 65–85%) at 96 h (Fig. 1A
nd B). CLA (1–200M) inhibited basal leptin secretion at 96 h
y −30% to −40% (P < 0.05–0.01) (Fig. 1C). As expected,
nsulin at 1.6 nM increased (P < 0.001) leptin secretion (by
40%). Co-treatment with CLA at the higher concentrations
50–200M) in the presence of insulin decreased insulin-
timulated leptin secretion by −20% to −40% (P < 0.01)
Fig. 1D).
.2. Effects of CLA on adiponectin secretion
CLA (50–200M) inhibited basal adiponectin secretion
268.0 ± 93.3 ng/ml) by −20% to −40% (P < 0.05–0.01)
Fig. 2A). However, co-treatment of adipocytes with insulin pre-
ented the inhibitory action of CLA on adiponectin production,
ith the exception of a non-significant trend towards inhibition
t the highest CLA concentration of 200M (P = 0.08) (Fig. 2B)..3. Effects of CLA on glucose utilization
CLA at concentrations of 50–200M decreased basal glu-
ose utilization over 96 h by −20% to −30% (P < 0.05–0.01).
RNA expression, as assessed by Northern blots. The expression level of 18S
ion in total RNA amount. Results are representative of at least two independent
ulated (D) leptin secretion by isolated rat adipocytes over 96 h in culture (n = 8,
d insulin treatment) and bP < 0.01 vs. cells incubated with insulin alone.
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Fig. 2. Effects of CLA (1–200M) on adiponectin secretion by isolated rat
adipocytes both in absence (A) and in presence of 1.6 nM insulin (B) (n = 5,
media ± S.E., expressed as percentage of control).*P < 0.05 and **P < 0.01 vs.
control (cells without CLA and insulin treatment).
Fig. 3. Effects of CLA (50–200M) in absence or presence of 1.6 nM insulin
on glucose uptake by isolated adipocytes over 96 h in culture. Data (n = 6,
mean ± S.E.). *P < 0.05, **P < 0.01 vs. control (cells without CLA and insulin
t
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Fig. 4. Relationship between glucose uptake and both leptin (A and B) and adipone
respectively, in control and CLA-treated cells (1–200M) over 96 h of culture.reatment) and aP < 0.05 vs. cells incubated with insulin alone.
nsulin-stimulated glucose utilization was only significantly
nhibited by CLA at the highest concentration examined,
00M (−16.4 ± 5.7%, P < 0.05) (Fig. 3). Adipocyte glucose
ptake and insulin-stimulated but not basal leptin secretion were
irectly correlated (Fig. 4A and B). A strong positive rela-
ionship was found between glucose uptake and adiponectin
ecretion, both in the absence and in the presence of insulin
Fig. 4C and D).
ctin secretion (C and D) in the absence and in the presence of 1.6 nM insulin,
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.4. Effects of CLA on lactate production
CLA did not modify basal lactate production. Insulin
ecreased lactate production by −27.0 ± 6.6% (P < 0.01). Co-
reatment with CLA at the concentrations of 50 and 200M
ncreased lactate production (+25.2 ± 7.7%, P < 0.01 for 50M
nd +19.5 ± 10.3%, P < 0.05 for 200M) (Fig. 5A).The proportion of glucose carbon metabolized to and released
s lactate over 96 h was significantly increased by CLA at the
ighest concentrations tested both in absence (50–200M) and
resence of insulin (50 and 200M) (Fig. 5B). The percentage of
m
9
−
t
ig. 5. Effects of CLA (50–200M) in absence or presence of 1.6 nM insulin on lact
y isolated adipocytes over 96 h in culture. Data (n = 6, mean ± S.E.). *P < 0.05, **P
P < 0.01 vs. cells incubated with insulin alone. Relationship between the percentag
ecretion (E and F) in the absence and in the presence of 1.6 nM insulin, respectivelylar Endocrinology 268 (2007) 50–58
lucose that was metabolized as lactate was inversely correlated
ith both leptin (Fig. 5C and D) and adiponectin production
Fig. 5E and F) in the absence and presence of insulin.
.5. Effects of CLA on lipolysis
The effects of CLA on lipolysis were evaluated by deter-
ining the amount of glycerol released into the media over
6 h of culture. CLA (1–200M) decreased basal lipolysis by
15 to −40% (P < 0.05–0.01) (Fig. 6A). CLA also decreased
he amount of glycerol released in the presence of insulin, but
ate production (A) and the percentage of glucose carbon released as lactate (B)
< 0.01 vs. control (cells without CLA and insulin treatment) and aP < 0.05 and
e of glucose metabolized to lactate and both leptin (C and D) and adiponectin
, in control and CLA-treated cells (1–200M) over 96 h of culture.
P. Pe´rez-Matute et al. / Molecular and Cellu
Fig. 6. Effects of CLA (1–200M) on lipolysis in absence (A) and presence
of 1.6 nM insulin (B) by isolated rat adipocytes over 96 h in culture (n = 8,
mean ± S.E.). *P < 0.05 and **P < 0.01 vs. control (cells without CLA and insulin
treatment) and bP < 0.01 vs. cells incubated with insulin alone.
Fig. 7. Effects of CLA (50–200M) on basal PPAR mRNA expression, as
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Assessed by Northern blots. The expression level of 18S ribosomal RNA was
etermined and used as an internal control to correct for minor variations in total
NA amount. Results are representative of at least two independent experiments.
nly at the highest concentrations tested (100 and 200M)
Fig. 6B).
.6. Effects of CLA on PPARγ expression
CLA decreased PPAR gene expression at concentrations of
0, 100 and 200M (∼85% of inhibition) (Fig. 7).
. Discussion
CLA consists of a group of positional and geometric isomers
f linoleic acid. The cis-9, trans-11 (c9t11) isomer is the most
bundant natural isomer present in ruminant tissue fats and in
ilk and other dairy products. Some studies have suggested that
he trans-10, cis-12 CLA isomer (t10c12) is the isomer respon-
ible for decreasing fat mass (Wang and Jones, 2004a,b), while
he adverse effects on insulin sensitivity after CLA treatment are
i
m
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ssociated with the t10c12 isomer (Clement et al., 2002; Riserus
t al., 2002). In the present study, we used a commercially avail-
ble mixture of both CLA isomers, which consisted of ∼40%
f 9c11t isomer and ∼40% of the 10t12c isomer. Hargrave et
l. (2002) reported a decrease in body fat in mice treated with a
ixture of CLA isomers as well as with the t10c12 CLA isomer
lone.
The present results demonstrate a direct inhibitory effect of
LA on both basal and insulin-stimulated leptin gene expression
nd secretion. This suggests that CLA treatment can inhibit lep-
in production directly, and that decreases in circulating leptin
evels reported in animal studies may not be solely a conse-
uence of reduced fat mass (Yamasaki et al., 2003). This is
upported by a human study in which CLA supplemented at
% of energy requirements modestly decreased circulating lep-
in concentration, but did not affect body weight or body fat
ontent (Medina et al., 2000). The inhibitory effect on basal
eptin production seems to be specific for CLA since linoleic
cid did not modify basal leptin secretion in primary cultured
at adipocytes (data not shown). Kang and Pariza (2001) also
bserved that 100M of the t10c12 isomer directly inhibited
eptin secretion and gene expression in 3T3-L1 cells. However,
rown et al. (2004) reported a stimulatory effect of t10c12 CLA
somer on leptin gene expression in cultures of stromal vascu-
ar cells containing newly differentiated human adipocytes after
days of treatment. The disparity with our results is likely to
e related to differences in the type of culture system employed
differentiating cultures of human SV cells versus collagen-fixed
rimary rat adipocytes).
Both a recent study in 3T3-L1 cells and a previous study in
rown adipocytes observed that CLA isomers exhibited opposite
ffects on leptin. Thus, t10c12 CLA reduced while c9t11 CLA
ended to increase leptin secretion or gene expression, respec-
ively (Rodriguez et al., 2002; Ahn et al., 2006). The inhibitory
ction on leptin observed in our study using a mixture with
imilar concentrations of both CLA isomers, suggests that the
resence of c9t11 CLA is not able to counteract the inhibitory
ction of t10c12 CLA.
Previous studies conducted in animals have described an
poptotic effect of CLA on white adipose tissue (Tsuboyama-
asaoka et al., 2000). However, Brown et al. (2004) observed in
rimary cultured human adipocytes that cell numbers were not
educed after CLA treatment. Although we did not specifically
easure apoptosis in these studies, the lack of effects of CLA on
8S ribosomal mRNA levels suggests that CLA did not exert an
poptotic action in the present studies. Therefore, the decrease
n leptin secretion induced by CLA is more likely to be related to
he inhibitory effect of CLA on leptin gene transcription rather
han to a reduction of adipocyte number.
Several previous studies indicate that insulin-stimulated glu-
ose metabolism rather than insulin per se is involved in the
egulation of leptin production (Mueller et al., 1998; Moreno-
liaga et al., 2001). Inhibitors of glucose uptake and metabolismnhibit insulin-stimulated leptin secretion in proportion to their
etabolic effects (Mueller et al., 1998). One study reported
hat CLA supplementation decreased adipose tissue GLUT-4
insulin dependent glucose transporter) gene expression in mice
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eanwhile a significant increase of GLUT4 gene expression was
bserved in gastrocnemious muscle (Tsuboyama-Kasaoka et al.,
000). In this study, we observed that CLA decreased basal glu-
ose uptake at every concentration studied. Insulin-stimulated
lucose uptake was only inhibited by CLA at the highest con-
entration (200M), suggesting that insulin may override the
nhibitory effects of CLA on glucose uptake. However, a strong
elationship between glucose uptake and leptin production was
bserved in the presence, but not in the absence, of insulin sug-
esting that glucose uptake per se is not the main determinant
f the inhibitory actions of CLA on leptin production. In fact,
e have published data suggesting that aerobic metabolism of
lucose beyond pyruvate, and not glucose utilization per se, is
nvolved in the effects of glucose and insulin to increase leptin
ecretion (Havel, 2000; Mueller et al., 2000). In these experi-
ents, leptin secretion was inversely related to the proportion
f glucose anaerobically metabolized to lactate. In the present
tudy, basal lactate production was unaffected by incubation
ith CLA, however, the percentage of glucose carbon metab-
lized to lactate was increased both in absence and in presence
f insulin and was strongly inversely correlated to leptin produc-
ion across all concentrations of CLA. These results suggest that
he decrease observed in leptin secretion and expression induced
y CLA may result from the effects of CLA to increase pro-
ortional anaerobic glucose metabolism. Previous studies have
lso suggested that glucose utilization stimulates leptin produc-
ion by directing the metabolism of glucose to a fate other than
naerobic lactate production, mainly to oxidation or lipogenesis
Havel et al., 1999a; Mueller et al., 2000). In the present study,
e did not observe any significant effect of CLA on both the per-
entage of glucose that is incorporated into triglyceride or that is
xidized to CO2, although a moderate trend towards inhibition
as observed in the proportion of glucose that was oxidized to
O2 after CLA treatment (data not shown).
It has been suggested that increased lipolysis (and also ele-
ated cAMP) is negatively related to leptin release by adipocytes
Fain and Bahouth, 2000; Moreno-Aliaga et al., 2002). Sev-
ral studies have described a lipolytic effect of CLA in murine
nd human adipocytes (Park et al., 1997, 1999; Evans et al.,
002; Chung et al., 2005; Simon et al., 2005). However, other
tudies have not observed any effect of short-term intake of
LA on basal lipolysis in mouse adipose tissue (Xu et al.,
003). In the current study, basal lipolysis was significantly
educed during incubation with CLA at all concentrations tested
nd an inhibitory effect was also observed in the presence of
nsulin at the higher concentrations of CLA (100–200M).
hus, CLA-induced inhibition of leptin gene expression and
ecretion observed in the present study is unlikely to be related
o increased lipolysis.
Adiponectin is an adipocyte hormone with anti-inflammatory
nd insulin-sensitizing properties. Circulating adiponectin con-
entrations are reduced in obese individuals and negatively
orrelated with increasing adiposity in humans and animals
Hotta et al., 2001; Stefan et al., 2002a; Cnop et al., 2003; Havel,
004). The majority of studies conducted in animals demon-
trate that CLA reduces body fat mass (DeLany et al., 1999;
ang and Jones, 2004a,b). However, it has been reported that
t
T
clar Endocrinology 268 (2007) 50–58
LA decreases adiponectin production in mice (Ohashi et al.,
004; Poirier et al., 2005), an effect opposite to what would
e expected with a reduction in fat mass. This suggests that
LA may have a direct inhibitory action on adiponectin pro-
uction. In the present study, we demonstrate for the first time
hat a mixture of CLA isomers inhibits adiponectin secretion
rom cultured isolated adipocytes. On the contrary, a recent study
sing separately both types of CLA isomers observed a slightly
ncrease in adiponectin by the 9c11t isomer and no effects with
he 10t12c isomer in 3T3-L1 cells (Ahn et al., 2006). The dispar-
ty observed between both studies could be related to a potential
ifferent action of CLA isomers on adiponectin when adminis-
ered together than separately, but could also be related to type of
ulture system employed (3T3-L1 cells versus primary cultured
dipocytes) and period of treatment.
The data suggest that a reduction in glucose utilization may
e involved in the inhibitory actions of CLA on adiponectin. We
bserved a strong inverse relationship between glucose utiliza-
ion by the adipocytes and adiponectin secretion, suggesting that
lucose uptake may be necessary in order to secrete adiponectin.
urthermore, insulin was able to partially prevent the inhibitory
ffects of CLA on both glucose uptake and adiponectin secre-
ion. In a recent study, adiponectin protein content in 3T3-L1
ells was decreased by glucose deprivation (Huypens et al.,
005). However, in this study incubation 3T3-L1 cells with
etformin, which stimulates adipocyte glucose uptake (Mueller
t al., 2000), also inhibited adiponectin protein expression and
elease, and the inhibition was related to activation of AMP-
ctivated protein kinase (Huypens et al., 2005). In a previous
tudy, we demonstrated that although metformin does increase
lucose uptake, it also increases anaerobic metabolism of glu-
ose to lactate and as previously discussed, this effect was
nversely related to leptin secretion (Mueller et al., 2000). In
he present study, and similarly to what was observed for leptin,
he CLA-induced increase in the proportion of glucose metabo-
ized to lactate was inversely correlated to adiponectin secretion.
hese results suggest that the glucose metabolism rather than
lucose uptake per se is likely to be involved in the regulation
f both leptin and adiponectin production by adipose tissue.
A number of studies have reported that the insulin-sensitizing
lass of drugs, thiazolidinediones, which are agonists of PPAR,
ncrease both adiponectin gene expression in adipose tissue and
irculating adiponectin levels (Combs et al., 2002). It has been
uggested that increased adiponectin production is a mechanism
y which this class of compounds acts to improve whole-body
nsulin sensitivity (Yamauchi et al., 2001). Incubating cells
n vitro with the t10c12 isomer of CLA decreased PPAR
ene expression in 3T3-L1 cells and in human preadipocytes
Granlund et al., 2003; Kang et al., 2003). Our data confirm that
LA also decreases PPAR gene expression in primary cultured
at adipocytes and suggest that downregulation of PPAR con-
ributes to the observed inhibition of adiponectin secretion by
LA.In summary, CLA inhibited leptin gene expression and secre-
ion and adiponectin secretion in vitro in primary rat adipocytes.
hese inhibitory effects were correlated with alterations in glu-
ose metabolism, specifically with an increase in the anaerobic
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etabolism of glucose to lactate. The CLA-induced decrease in
diponectin secretion may also be mediated in part by inhibition
f PPAR gene expression. Inhibition of leptin and adiponectin
roduction by CLA may contribute to the decreases in whole-
ody insulin sensitivity observed in CLA-treated animals and
umans.
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